Financings in Brief: Gamera Bioscience
This article was originally published in The Gray Sheet
Executive Summary
Gamera Bioscience: Private placement financing of $4.5 mil. is completed with venture syndicate consisting of Spray Venture Fund, Advent International and Bessemer Venture Partners. Funding will go towards development of the firm's LabCD System platform technology. The system, which incorporates "a modified CD player and disposable compact discs" and is designed to perform "sophisticated laboratory tests at the point-of-care," is expected to be "the first portable, automated device able to perform the full spectrum of analytical tests, including cell counting, DNA analysis, immunoassays and clinical chemistries," Gamera states...
You may also be interested in...
US FDA’s Unapproved Drug Initiative Nixed, But Without Agency Buy-In Demise May Be Short-Lived
Trump administration effort to reduce drug prices by curtailing agency program requiring new approvals for some old products undermines FDA’s role in policing the safety of prescription drugs, experts say.
E.l.f. Has A Go At Twitch Crowd, Hitching Wagon To #Loserfruit
The maker of prestige-inspired cosmetics at value prices follows its TikTok viral success by teaming with Kathleen Belsten, aka Loserfruit, the second most-followed female gamer on the Amazon-owned livestreaming platform Twitch.
An Oversupply Of COVID Antibody Treatments? Multiple Monoclonal Products Raise Potential For Errors
As distribution of Regeneron’s monoclonal antibody treatment for coronavirus begins, OWS officials worry about provider confusion with Lilly’s product due to differences in preparation and administration.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: